• 1
    Kogevinas M, Porta M. Socioeconomic differences in cancer survival: a review of the evidence. In: KogevinasM, PearceN, SusserM, BoffettaP, eds. Social Inequalities and Cancer. IARC Scientific Pub. No 138. Lyon, France: International Agency for Research on Cancer; 1997: 177-206.
  • 2
    Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol. 2006; 17: 5-19.
  • 3
    Du XL, Fang S, Coker AL, et al. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 2006; 106: 1276-1285.
  • 4
    Carsin AE, Sharp L, Cronin-Fenton DP, Ceilleachair AO, Comber H. Inequity in colorectal cancer treatment and outcomes: a population-based study. Br J Cancer. 2008; 99: 266-274.
  • 5
    Downs LS, Smith JS, Scarinci I, Flowers L, Parham G. The disparity of cervical cancer in diverse populations. Gynecol Oncol. 2008; 109: S22-S30.
  • 6
    Bouchardy C, Verkooijen HM, Fioretta G. Social class is an important and independent prognostic factor of breast cancer mortality. Int J Cancer. 2006; 119: 1145-1151.
  • 7
    Gilligan T, Wang PS, Levin R, Kantoff PW, Avorn J. Racial differences in screening for prostate cancer in the elderly. Arch Intern Med. 2004; 164: 1858-1864.
  • 8
    Liu L, Cozen W, Bernstein L, Ross RK, Deapen D. Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst. 2001; 93: 705-709.
  • 9
    Conlisk EA, Lengerich EJ, Demark-Wahnefried W, Schildkraut JM, Aldrich TE. Prostate cancer: demographic and behavioral correlates of stage at diagnosis among blacks and whites in North Carolina. Urology. 1999; 53: 1194-1199.
  • 10
    Tarman GJ, Kane CJ, Moul JW, et al. Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology. 2000; 56: 1016-1020.
  • 11
    Harvei S, Kravdal O. The importance of marital and socioeconomic status in incidence and survival of prostate cancer. An analysis of complete Norwegian birth cohorts. Prev Med. 1997; 26: 623-632.
  • 12
    Gorey KM, Holowaty EJ, Fehringer G, Laukkanen E, Richter NL, Meyer CM. An international comparison of cancer survival: metropolitan Toronto, Ontario, and Honolulu, Hawaii. Am J Public Health. 2000; 90: 1866-1872.
  • 13
    Byers TE, Wolf HJ, Bauer KR, et al. The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer. 2008; 113: 582-591.
  • 14
    Clark JY, Thompson I. Military rank as a measure of socioeconomic status and survival from prostate cancer. South Med J. 1994; 87: 1141-1144.
  • 15
    Braveman PA, Cubbin C, Egerter SS, et al. Socioeconomic status in health research: one size does not fit all. JAMA. 2005; 294: 2879-2888.
  • 16
    Dutta RS, Philip J, Javle P. Trends in prostate cancer incidence and survival in various socioeconomic classes: a population-based study. Int J Urol. 2006; 13: 1364.
  • 17
    Desch CE, Penberthy L, Newschaffer CJ, et al. Factors that determine the treatment for local and regional prostate cancer. Med Care. 1996; 34: 152-162.
  • 18
    Optenberg SA, Thompson IM, Friedrichs P, Wojcik B, Stein CR, Kramer B. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA. 1995; 274: 1599-1605.
  • 19
    Reinhardt UE. The Swiss health system: regulated competition without managed care. JAMA. 2004; 292: 1227-1231.
  • 20
    European Observatory on Health Care Systems. Health Care Systems in Transition–Switzerland. European Observatory on Health Care Systems and Policies. Available at: Accessed December 2008.
  • 21
    Crivelli L. The end of universal coverage has been averted. Available at: Accessed December 2008.
  • 22
    Office Federal de la Statistique (OFS), eds. Classification des professions, des situations dans la profession, des classes economiques, utilisees pour le chiffrement des bulletins statistiques du mouvement de la population. Berne, Switzerland: Bureau Federal de la Statistique; 1979.
  • 23
    Leete R, Fox AJ. Registrar General's social classes: origins and uses. Popul Trends. 1977; 8: 1-7.
  • 24
    Bouchardy C, Schuler G, Minder C, et al. Cancer risk by occupation and socioeconomic group among men-a study by the Association of Swiss Cancer Registries. Scand J Work Environ Health. 2002; 28( suppl 1): 1-88.
  • 25
    HermanekP, SobinLH, eds. TNM Classification of Malignant Tumours. 2nd rev. 4th ed. Berlin: Springer Verlag; 1992.
  • 26
    SobinLH, WittekindCh, eds. TNM Classification of Malignant Tumours. 6th ed. New York: John Wiley & Sons Inc; 2002.
  • 27
    Clegg LX, Reichman ME, Miller BA, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control. 2009; 20: 417-435.
  • 28
    Polednak AP. Prostate cancer treatment in black and white men: the need to consider both stage at diagnosis and socioeconomic status. J Natl Med Assoc. 1998; 90: 101-104.
  • 29
    Meng MV, Elkin EP, Harlan SR, Mehta SS, Lubeck DP, Carroll PR. Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE. J Urol. 2003; 170: 2279-2283.
  • 30
    Robbins AS, Koppie TM, Gomez SL, Parikh-Patel A, Mills PK. Differences in prognostic factors and survival among white and Asian men with prostate cancer, California, 1995-2004. Cancer. 2007; 110: 1255-1263.
  • 31
    Merglen A, Schmidlin F, Fioretta G, et al. Short- and long-term mortality with localized prostate cancer. Arch Intern Med. 2007; 167: 1944-1950.
  • 32
    Basche M, Byers T. Re: Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst. 2001; 93: 64-65.
  • 33
    Robbins AS, Yin D, Parikh-Patel A. Differences in prognostic factors and survival among White men and Black men with prostate cancer, California, 1995-2004. Am J Epidemiol. 2007; 166: 71-78.
  • 34
    Davey SG, Neaton JD, Wentworth D, Stamler R, Stamler J. Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Lancet. 1998; 351: 934-939.